F. Chast

759 total citations
38 papers, 550 citations indexed

About

F. Chast is a scholar working on Public Health, Environmental and Occupational Health, Ophthalmology and Infectious Diseases. According to data from OpenAlex, F. Chast has authored 38 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 8 papers in Ophthalmology and 7 papers in Infectious Diseases. Recurrent topics in F. Chast's work include Ocular Surface and Contact Lens (9 papers), Ocular Infections and Treatments (5 papers) and Advanced Drug Delivery Systems (5 papers). F. Chast is often cited by papers focused on Ocular Surface and Contact Lens (9 papers), Ocular Infections and Treatments (5 papers) and Advanced Drug Delivery Systems (5 papers). F. Chast collaborates with scholars based in France, Canada and New Zealand. F. Chast's co-authors include Christophe Bardin, Michel Baudry, J.C. Schwartz, Rui Batista, Gillian Barratt, Amélie Bochot, Angelo Bartoletti, J.C. Chaumeil, Hugues Michelon and Jacques Gilquin and has published in prestigious journals such as Journal of Neurochemistry, The Journal of Infectious Diseases and British Journal of Cancer.

In The Last Decade

F. Chast

37 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Chast France	14	170	138	99	98	93	38	550
S. Hariharan United States	14	108 0.6×	70 0.5×	101 1.0×	87 0.9×	117 1.3×	37	679
Pierre Comby France	9	69 0.4×	292 2.1×	28 0.3×	119 1.2×	33 0.4×	12	525
Kenichi Nishimura Japan	14	131 0.8×	34 0.2×	23 0.2×	58 0.6×	36 0.4×	66	546
Becky Chandler United Kingdom	13	89 0.5×	382 2.8×	45 0.5×	96 1.0×	16 0.2×	16	659
Rachel Courtney United States	14	314 1.8×	802 5.8×	47 0.5×	661 6.7×	54 0.6×	18	1.7k
J. R. Lowe United Kingdom	11	302 1.8×	106 0.8×	49 0.5×	54 0.6×	7 0.1×	23	623
Julie Smet Belgium	13	67 0.4×	78 0.6×	23 0.2×	128 1.3×	5 0.1×	29	673
Chengwen Teng United States	13	208 1.2×	122 0.9×	21 0.2×	90 0.9×	5 0.1×	27	638
Jennifer J. Harris United States	10	84 0.5×	29 0.2×	68 0.7×	43 0.4×	11 0.1×	10	430
Christa E. Nath Australia	19	220 1.3×	158 1.1×	163 1.6×	127 1.3×	18 0.2×	49	881

Countries citing papers authored by F. Chast

Since Specialization

Citations

This map shows the geographic impact of F. Chast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Chast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Chast more than expected).

Fields of papers citing papers by F. Chast

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Chast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Chast. The network helps show where F. Chast may publish in the future.

Co-authorship network of co-authors of F. Chast

This figure shows the co-authorship network connecting the top 25 collaborators of F. Chast. A scholar is included among the top collaborators of F. Chast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Chast. F. Chast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dinh, Aurélien, Hafedh Fessi, Clara Duran, et al.. (2018). Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study. Journal of Hospital Infection. 99(4). 481–486. 59 indexed citations

Davido, Benjamin, Rui Batista, Hugues Michelon, et al.. (2017). Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?. Journal of Hospital Infection. 95(4). 433–437. 66 indexed citations

Avouac, Jérôme, Anna Moltó, Marie Dior, et al.. (2017). P471 Efficacy and safety of switching from reference infliximab to biosimilar infliximab in patients with inflammatory bowel disease: first French experience. Journal of Crohn s and Colitis. 11(suppl_1). S318–S319. 4 indexed citations

Chast, F., et al.. (2016). Impact du pharmacien clinicien à l’hôpital pour prévenir les posologies supra-thérapeutiques du paracétamol. Annales Pharmaceutiques Françaises. 74(6). 482–488. 5 indexed citations

Chast, F., et al.. (2015). Collyres de ciclosporine : étude d’une cohorte de patients de 2009 à 2013. Journal Français d Ophtalmologie. 38(8). 700–708. 15 indexed citations

Batista, Rui, Nathalie Kapel, J.C. Chaumeil, et al.. (2015). Le transfert de microbiote fécal lors d’infections récidivantes à Clostridium difficile. Cadre et aspects pharmacotechniques. Annales Pharmaceutiques Françaises. 73(5). 323–331. 5 indexed citations

Chast, F.. (2013). Mise au pointHistoire de la corticothérapieHistory of corticotherapy. La Revue de Médecine Interne. 34(5). 2 indexed citations

Chast, F.. (2013). Histoire de la corticothérapie. La Revue de Médecine Interne. 34(5). 258–263. 5 indexed citations

Chast, F.. (2009). L’histoire des Annales pharmaceutiques françaises. 1809–2009. Annales Pharmaceutiques Françaises. 67(6). 380–390. 1 indexed citations

10.

Doan, Serge, et al.. (2007). Efficacité de la ciclosporine A en collyre à 2 % en tant qu’épargneur de corticoïdes dans le traitement de la kératoconjonctivite vernale corticodépendante. Journal Français d Ophtalmologie. 30(7). 697–701. 19 indexed citations

11.

Bartoletti, Angelo, et al.. (2007). Liposomal amphotericin B eye drops to treat fungal keratitis: Physico-chemical and formulation stability. International Journal of Pharmaceutics. 344(1-2). 150–153. 57 indexed citations

12.

Chast, F.. (2006). John R. Vane, « pharmacologue de l’endothélium vasculaire », 1927–2004. Annales Pharmaceutiques Françaises. 64(6). 416–424. 1 indexed citations

13.

Chast, F., et al.. (2004). Préparation d’un collyre de ciclosporine à 2 %. Journal Français d Ophtalmologie. 27(6). 567–576. 13 indexed citations

14.

Batista, Rui, et al.. (2004). Dosage plasmatique des énantiomères de la méthadone par chromatographie liquide à haute performance. Annales Pharmaceutiques Françaises. 62(3). 193–200. 2 indexed citations

15.

Chast, F.. (2000). [Apollinaire Bouchardat, pharmacist, nutritionist].. PubMed. 58(6 Suppl). 435–42. 2 indexed citations

16.

Piketty, Christophe, Christophe Bardin, Jacques Gilquin, et al.. (2000). Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis. Clinical Microbiology and Infection. 6(3). 117–120. 30 indexed citations

17.

Piketty, Christophe, Christophe Bardin, Jacques Gilquin, et al.. (1996). Low Plasma Concentrations Achieved with Conventional Schedules of Administration of Ganciclovir in Patients with AIDS. The Journal of Infectious Diseases. 174(1). 188–190. 19 indexed citations

18.

Legrand, O., et al.. (1993). CEFTAZIDIME : AVANTAGES DES PERFUSIONS CONTINUES CHEZ UN MALADE EN APLASIE. La Presse Médicale. 22(16). 786–786. 2 indexed citations

19.

Chast, F., et al.. (1992). Quels sont les coûts des différentes méthodes de prophylaxie ?. Annales Françaises d Anesthésie et de Réanimation. 11(3). 335–340. 1 indexed citations

20.

Dumortier, G., Mathieu Zuber, F. Chast, P. Sandouk, & J.C. Chaumeil. (1990). Systemic absorption of morphine after ocular administration: evaluation of morphine salt insert in vitro and in vivo. International Journal of Pharmaceutics. 59(1). 1–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact